- 178Market reports
- 146With size & growth
- 35Markets with active clinical trials
- 12+Key companies named
Fastest-growing in Middle East
2023–2033 CAGR · estimates
- 1Blockchain in Genomics 39.3% $89 Mn → $2.5 Bn
- 2Artificial Intelligence (AI) Machine Learning(ML) in Healthcare 39% $76 Mn → $2 Bn
- 3Artificial Intelligence (AI) in Medicine 38.5% $332 Mn → $8.6 Bn
- 4Digital Biomarkers 36.5% $176 Mn → $4 Bn
- 5Artificial Intelligence (AI) in Remote Patient Monitoring 31.4% $36 Mn → $552 Mn
- 6Blockchain-as-a-Service 30.3% $84 Mn → $1.2 Bn
- 7Artificial Intelligence (AI) in Radiology 29.6% $24 Mn → $321 Mn
- 8Connected Healthcare Market 28.1% $2.4 Bn → $28 Bn
By category
- OTC & Nutraceuticals 48 reports Fastest: Cannabidiol (CBD) Supplements · 17.8% Top 10 OTC & Nutraceuticals in Middle East
- Digital Health 41 reports Fastest: Blockchain in Genomics · 39.3% Top 10 Digital Health in Middle East
- Pharmaceuticals 38 reports Fastest: Biosimilars · 25.9% Top 10 Pharmaceuticals in Middle East
- Medical Devices 27 reports Fastest: Anesthesia Monitoring Devices · 13.5% Top 10 Medical Devices in Middle East
- Healthcare Services 24 reports Fastest: Patient Support Programs (PSP) · 16.8% Top 10 Healthcare Services in Middle East
Biggest markets in Middle East
Market size in 2023
Most clinical trials in Middle East
Active trials (recruiting, about to start or running) in UAE, Saudi Arabia
Health in Middle East: WHO figures
| Measure | UAE | Saudi Arabia |
|---|---|---|
| Diabetes (adults) % of adults | 26.1 2022 | 20.8 2022 |
| Obesity (adults) % of adults | 31.6 2024 | 40.1 2024 |
| High blood pressure (ages 30–79) % of adults 30–79 | 41.4 2019 | 34.0 2019 |
| Anaemia in women 15–49 % of women | 28.2 2023 | 17.6 2023 |
| Universal health coverage index index (0–100) | 84 2023 | 83 2023 |
| Road traffic deaths per 100,000 people | 5.1 2023 | 14.7 2023 |
| Healthy life expectancy years | 70.2 2023 | 66.5 2023 |
| Early deaths from long-term diseases % | 6.8 2023 | 14.4 2023 |
| Tobacco use (adults) % of adults | 8.8 2025 | 14.7 2025 |
| Not active enough (adults) % of adults | 66.1 2022 | 51.5 2022 |
| Alcohol drunk per person litres of pure alcohol (15+) | 0.6 2024 | – |
| Fine dust in the air (PM2.5) µg per m³ | 34.0 2023 | 43.9 2023 |
Middle East: People and health spending
| Measure | UAE | Saudi Arabia |
|---|---|---|
| Population people | 11.5 million 2025 | 37.0 million 2025 |
| Life expectancy at birth years | 83.1 2024 | 79.0 2024 |
| People aged 65 and over % of people | 1.8 2025 | 3.1 2025 |
| Health spending per person US$ per person | 2,402 2023 | 1,825 2023 |
| Health spending (% of GDP) % of GDP | 5.0 2023 | 5.7 2023 |
| Out-of-pocket spending % of health spending | 9.7 2023 | 14.1 2023 |
| Doctors per 1,000 people | 2.99 2023 | 3.41 2023 |
| Nurses and midwives per 1,000 people | 6.19 2022 | 6.56 2023 |
| Hospital beds per 1,000 people | 1.87 2022 | 2.41 2023 |
Companies most covered in Middle East
Medtronic30 reports
Johnson & Johnson27 reports
Abbott Laboratories25 reports
Pfizer Inc.24 reports
GE Healthcare23 reports
Siemens Healthineers21 reports
Novartis AG19 reports
Philips Healthcare16 reports
Merck & Co., Inc.15 reports
Sanofi15 reports
Bayer AG15 reports
IBM Watson Health13 reports
All 178 Middle East markets
Each market name opens its Middle East report. To compare one market across every country, see market statistics.
Digital Health 41 markets
Healthcare Services 24 markets
| Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|
| Alopecia areata | – | – | – | 0 |
| Alzheimers Dignostic | $84 Mn | $180 Mn | 7.9% | 5 |
| Ambulance Service | $1.3 Bn | $2.7 Bn | 8.1% | 10 |
| Ambulatory Surgery Center | $1.6 Bn | $3.2 Bn | 7.1% | 84 |
| Antimicrobial Susceptibility Testing | – | – | – | 1 |
| Bioinformatics | $488 Mn | $2 Bn | 15.4% | – |
| Biomaterial Wound Dressing | $328 Mn | $689 Mn | 7.7% | 0 |
| Blood Gas and Electrolyte Analyzers | $112 Mn | $229 Mn | 7.4% | 5 |
| Bone Cancer Diagnostic | $44 Mn | $99 Mn | 8.4% | 5 |
| Brain Cancer Diagnostic | $60 Mn | $234 Mn | 14.6% | 4 |
| Breast Cancer Diagnostic | $164 Mn | $381 Mn | 8.8% | 18 |
| Clinical Laboratory Service | – | – | – | – |
| Dental Care Service | – | – | – | – |
| Dental Imaging | $136 Mn | $319 Mn | 8.9% | – |
| Dermatology Diagnostic | $1 Bn | $3.3 Bn | 12.2% | 17 |
| Fertility Service | $840 Mn | $1.7 Bn | 7.1% | – |
| Healthcare Electronic Data Interchange (EDI) | $160 Mn | $430 Mn | 10.4% | 1 |
| Healthcare In Vitro Diagnostic | $3.3 Bn | $5.3 Bn | 4.8% | 4 |
| Hospitals and Health Systems | $174.3 Bn | $330.2 Bn | 6.6% | 274 |
| Medical Billing | $180 Mn | $579 Mn | 12.4% | 0 |
| Medical Tourism | $3 Bn | $10.3 Bn | 13.2% | 0 |
| Nursing Education | $412 Mn | $984 Mn | 9.1% | 6 |
| Patient Support Programs (PSP) | $688 Mn | $2.4 Bn | 16.8% | 11 |
| Point Of Care (PoC) Molecular Diagnostic | $748 Mn | $2 Bn | 10.3% | 12 |
Medical Devices 27 markets
| Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|
| Acute Care Needleless Connectors | $20 Mn | $44 Mn | 8.5% | – |
| Advanced Bipolar Direct Energy Devices | $124 Mn | $313 Mn | 9.7% | – |
| Aesthetic Lasers and Energy Devices | $65 Mn | $222 Mn | 13.1% | – |
| Air Ambulance Life Support Solutions | $179 Mn | $468 Mn | 10.1% | – |
| Airway Management Devices | $80 Mn | $146 Mn | 6.2% | – |
| Anastomosis Devices | $126 Mn | $267 Mn | 7.8% | – |
| Anesthesia & Respiratory Devices | $1.1 Bn | $3.1 Bn | 10.5% | – |
| Anesthesia Monitoring Devices | $106 Mn | $375 Mn | 13.5% | – |
| Angiography Devices | $498 Mn | $1 Bn | 7.3% | – |
| Angioplasty Balloons | $162 Mn | $260 Mn | 4.8% | – |
| Anti-Snoring Devices | $50 Mn | $127 Mn | 9.8% | – |
| Apheresis Equipments | $102 Mn | $204 Mn | 7.2% | – |
| Arrhythmia Monitoring Devices | $240 Mn | $451 Mn | 6.5% | – |
| Assisted Walking Aids | $92 Mn | $173 Mn | 6.5% | – |
| Audiology Devices | $313 Mn | $640 Mn | 7.4% | – |
| Defibrillator | $709 Mn | $1.4 Bn | 6.9% | – |
| Dental Articulators | $16 Mn | $32 Mn | 7.4% | – |
| Dental Caries Detectors | $15 Mn | $49 Mn | 12.8% | – |
| Dental Diagnostic and Surgical Equipments | $479 Mn | $1 Bn | 8.1% | – |
| Dental X-Ray Equipments | $70 Mn | $154 Mn | 8.2% | – |
| Diabetes Care Devices | $1.7 Bn | $3.3 Bn | 6.9% | – |
| Digital Diabetes Management | – | – | – | – |
| Direct Energy Medical Devices | $442 Mn | $791 Mn | 6% | – |
| Disposable Surgical Devices | $362 Mn | $803 Mn | 8.3% | – |
| Insulin Delivery Devices | $636 Mn | $1.3 Bn | 7.5% | – |
| Insulin Patch Pumps | $36 Mn | $121 Mn | 13% | – |
| Rehabilitation Equipments | $800 Mn | $1.6 Bn | 7.1% | – |
OTC & Nutraceuticals 48 markets
Pharmaceuticals 38 markets
"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.
Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.